Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New Elite Feature:   Find Similar Charts in Seconds

Learn How
Market News Market Pulse Stocks News ETF News Crypto News

Certara

Contributing Author

Recent Articles by Certara

Aug-04
Certara Reports Second Quarter 2026 Financial Results CERT GlobeNewswire
Jul-15
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026 CERT +5.85% GlobeNewswire
Jul-07
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit CERT GlobeNewswire
Jun-17
Certara Announces CFO Transition CERT CERT -8.13% GlobeNewswire
May-18
Certara to Participate in Upcoming Investor Conferences CERT GlobeNewswire
May-11
Certara Reports First Quarter 2026 Financial Results CERT -18.70% GlobeNewswire
Apr-22
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat CERT GlobeNewswire
Apr-09
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026 CERT GlobeNewswire
Mar-03
Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib CERT GlobeNewswire
Feb-27
Certara to Participate in Upcoming Investor Conferences CERT GlobeNewswire
Feb-26
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance CERT GlobeNewswire
Jan-29
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025 CERT GlobeNewswire
Dec-11
Certara Appoints Jon Resnick as Chief Executive Officer CERT -5.06% GlobeNewswire
Nov-06
Certara Reports Third Quarter 2025 Financial Results CERT CERT -23.07% GlobeNewswire
Nov-04
Certara Automates Scientific Workflows with Phoenix Cloud CERT GlobeNewswire
Oct-31
Certara to Participate in Upcoming Investor Conferences CERT GlobeNewswire
Oct-30
Certara Expands Biosimulation Market with AI-Driven QSP Platform CERT GlobeNewswire
Oct-20
Certara Scientists are Among the Topmost Cited Biopharma Researchers CERT GlobeNewswire
Oct-10
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025 CERT -8.35% GlobeNewswire
Sep-04
Certara Launches Pinnacle 21 Enterprise Plus to Deliver Regulatory Submissions Faster CERT GlobeNewswire
Sep-02
Certara to Participate in Upcoming Investor Conferences CERT GlobeNewswire
Aug-06
Certara Reports Second Quarter 2025 Financial Results CERT CERT +18.15% GlobeNewswire
Aug-04
Certara Simcyp Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling CERT GlobeNewswire
Jul-31
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform CERT GlobeNewswire
Jul-09
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 CERT GlobeNewswire
Jul-08
Certara Announces Expansion of Clinical Technology Collaboration with Merck CERT GlobeNewswire
May-05
Certara Reports First Quarter 2025 Financial Results CERT CERT -11.03% GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)